Skip to content
← Full study record

NCT04140162 · MORE INFO

Limitations, agreements, and source contact

Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy · Source last updated 2026-07-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Participating Sites agree not to independently publish its Data or results from any analysis and disseminate information until the earlier of the date Michigan has published the results, one year after the termination of the study, or Michigan chooses not to proceed with publication. The sponsor will receive no less than 30 days to review any manuscript, abstract, poster, publication or presentation.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
ClinicalTrialsgov_CCAdmin@umich.edu
organization
University of Michigan Rogel Cancer Center
phone
734-936-9499
title
University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin
Complete source fields
certain Agreement
other Details
Participating Sites agree not to independently publish its Data or results from any analysis and disseminate information until the earlier of the date Michigan has published the results, one year after the termination of the study, or Michigan chooses not to proceed with publication. The sponsor will receive no less than 30 days to review any manuscript, abstract, poster, publication or presentation.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
ClinicalTrialsgov_CCAdmin@umich.edu
organization
University of Michigan Rogel Cancer Center
phone
734-936-9499
title
University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Independent clinical review pending · Not medical advice